Audientes expands distribution network to Nepal with collaboration agreement with M
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Audientes expands distribution network to Nepal with collaboration agreement with M.B. Meditech.

Press Release, no. 4-2023 - February 16, 2023: Audientes A/S and Nepal’s M.B. Meditech Pvt. Ltd. today announced a collaboration agreement for the distribution and sale of Audientes' self-fitting hearing aid, Ven™ by Audientes, throughout Nepal.

The agreement means that Ven will soon be available to Nepalese consumers via M.B. Meditech’s distribution network. M.B. Meditech is a hospital equipment and surgical supplier based in Kathmandu, Nepal with a goal to add hearing healthcare products to its catalog.  

A hugely underserved market

“We are very happy that Ven will soon be available in Nepal and warmly welcome M.B. Meditech to the Audientes partner network. Hearing loss in Nepal is among the highest per capita in Asia with approximately 16% of the entire population suffering from some form of hearing loss. With only one audiologist for every 600,000 people, and a lack of affordable quality hearing aids, Nepal is a hugely underserved market. This agreement with M.B. Meditech is an important first step towards making Ven available to the many people in Nepal who could benefit from it.” says Steen Thygesen, CEO, Audientes A/S.

Fills a gap in the market

Mr Sandeep Rawat, Director, M.B. Meditech comments: “We are very happy to begin introducing the Ven hearing aid to the hospitals in our distribution network.  I see great potential here because, not only is this is an entirely new product category for us, but it also fills a gap in the market for a do-it-yourself solution. I’m looking forward to seeing how it is received.”  

M.B. Meditech will commence distribution of Ven in Q1 2023.

Bifogade filer

Audientes and MB Meditech Nepal Collaboration agreement FINALhttps://mb.cision.com/Public/21235/3716650/849325308ae77f1e.pdf

Nyheter om Audientes

Läses av andra just nu

Om aktien Audientes

Senaste nytt